5 Articles
5 Articles
EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders - Adial Pharmaceuticals (NASDAQ:ADIL)
Adial secures USPTO patent for AD04, expanding coverage to treat alcohol and opioid-related disorders in patients with genetic markers.
JCI GLP-1 receptor agonists for the treatment of alcohol use disorder
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity. These medications primarily function by enhancing insulin secretion; however, emerging evidence suggests that the effects extend beyond metabolic regulation. In this issue of the JCI, Farokhnia et al. evaluated the effects of GLP-1RAs alongside another T2D treatment, dipe…
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
The success of weight loss drugs like Wegovy and Mounjaro has invigorated obesity research and especially the pursuit of new treatments for obesity. Many of these drugs are targeting glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide (GIPR) and glucagon receptor (GCGR), as well as other hormones involved in satiety and metabolism; some are using entirely novel mechanisms. Incretins are gut-derived hormones, m…
Insights into Alcohol Use Disorder Diagnosis and Treatment - Mpelembe Network
May 1, 2025 /Mpelembe Media/ — A new online survey conducted by The Harris Poll on behalf of Alkermes, Inc., a biopharmaceutical company focused on neuroscience, explores the experiences of individuals diagnosed with Alcohol Use Disorder (AUD). The survey of 300 adults with AUD aimed to understand their journey to diagnosis, reasons for seeking treatment, and the perceived impact of treatment on their lives. Key findings suggest that negative co…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage